These results suggest that CX3CR1/CX3CL1 biological axis may be a driver of dysregulated autoimmunity that favours SSc-ILD and may have an ability to predict SSc-ILD as well as its progression. This evidence concerns the gene CX3CL1 and systemic sclerosis.